Posts by: Carolina Henriques

Carolina Henriques

Carolina holds a BSc in Anthropology and a MSc in Urban Studies., and brings her interdisciplinary skills to her writing on a range of different topics in science, research and advocacy news.

April 12, 2016April 19, 2016

Quinsair Inhaled Therapy for Cystic Fibrosis Is Launched in Europe, Raptor Announces

Cystic Fibrosis, News

Raptor Pharmaceutical Corp. announced its first commercial sale of Quinsair, a levofloxacin inhalation solution, in Germany and Denmark. The European Union (EU) and Canada have already approved Quinsair for the management of ... Read more

April 12, 2016April 19, 2016

Pulmonary Fibrosis Foundation Enrolls First Patient in Newly Launched National Registry

Idiopathic Pulmonary Fibrosis, News

The Pulmonary Fibrosis Foundation (PFF) enrolled the first patient in its new PFF Patient Registry, the foundation’s inaugural research tool that will comprise a broad collection of data from PF patients ... Read more

April 11, 2016April 11, 2016

Asthma Survey Reports Most Patients Think Disease Is Controlled, but It’s Not

Asthma, News

According to a new survey, the Allergy and Asthma Network-led “Observations of Patient Experience in the Nation (OPEN) Asthma Survey,” people who suffer from asthma accept the disease-associated symptoms and limitations ... Read more

April 8, 2016April 8, 2016

Laurent Pharmaceuticals’ Drug Candidate for Cystic Fibrosis Supported by Anges Québec, Other Investors

Cystic Fibrosis, News

A series of Canadian so-called angel investors, primarily Anges Québec, are partnering with Aligo Innovation and other private investors to help Cystic Fibrosis Canada support the growth of Laurent Pharmaceuticals, a Montreal-based private biopharma ... Read more

April 8, 2016April 8, 2016

Uptravi for Treatment of PAH Gets Postive Opinion from EMA Committee; EC Decision Expected Soon

News, Pulmonary Hypertension

Actelion recently announced in a press release that the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has reconsidered and re-adopted its positive opinion for the ... Read more

April 6, 2016May 13, 2016

Pneumonia Epidemic on Rise in Beijing; Diagnoses Doubled in Children in 2015

News, Pneumonia

Investigators from the Capital Institute of Pediatrics in Beijing, China, identified an increase in infections caused by Mycoplasma pneumoniae almost a year ago. By December 2015, the pathogen had already been ... Read more

April 4, 2016April 4, 2016

In PAH Patients, Study Finds Combo Therapy Reduces Risk of Clinical Worsening

News, Pulmonary Hypertension

A new study found that the use of combination therapy in patients with pulmonary arterial hypertension (PAH) considerably reduced their risk of clinical worsening, compared to using a single therapy. The study, ... Read more

April 1, 2016May 13, 2016

Study Looks at Link Between Vitamin D in Pregnancy and Childhood Asthma

Asthma, News

According to a new study from a University of Kansas economist and colleagues, the most efficient way of reducing the chances of children developing asthma might be as simple as ensuring their ... Read more

March 31, 2016May 13, 2016

Stiolto Respimat for COPD Granted FDA’s Supplemental NDA Approval

Chronic Bronchitis, COPD, Emphysema, News

The FDA has approved a supplemental New Drug Application (sNDA) for Boehringer Ingelheim’s Stiolto Respimat, which, according to the company, adds data to the product’s label demonstrating improvements in health and quality ... Read more

March 30, 2016April 4, 2016

Cytori Updates Phase 3 Scleroderma Trial After Enrolling, Treating 40th Patient

News, Scleroderma

Cytori Therapeutics recently announced that its FDA-approved Phase 3 STAR clinical trial on ECCS-50 has enrolled and treated its 40th patient, reaching 50 percent of its target enrollment. Additionally, an independent ... Read more